Discover how selective peptide binders of RNF43 offer new hope for Wnt signaling inhibition in cancer treatment.
Discover how the RNF43 G659fs mutation in colorectal cancer creates a therapeutic vulnerability to PI3K/mTOR inhibitors, opening new precision medicine approaches.
Exploring the critical role of RNF43 mutations in serrated colorectal neoplasia and their implications for cancer treatment.